WGSearcher is a next-generation clinical genomics platform focused on somatic mutation detection and foreign DNA analysis—not inherited trait testing. Our mission is to support physicians with actionable, repeatable insights into a patient’s DNA during the course of diagnosis, treatment, and monitoring.
A Growing Need in clinical DNA analysis
Unlike one-time hereditary tests, clinical DNA analysis is fast, non-intrusive and dynamic. It needs to be repeated throughout the treatment cycle, for example:
- To get quick and comprehensive insight in foreign pathogens in a patient´s blood
- To search for potentially dangerous somatic mutations (for example yearly)
- To monitor disease evolution during treatment
- To track resistance mutations
- To assess treatment response in real time
This creates a recurring medical need—and a scalable business opportunity.
Our first focus is on foreign organisms and somatic mutation analysis from DNA files, working directly with clinicians in real-world settings. By partnering with trusted sequencing providers like Novogene, we streamline the entire process: from sample to actionable clinical report.
Why Invest in WGSearcher?
- 🧬 Clinical: We focus on DNA analysis for clinical diagnosis—fields with medical urgency and long-term relevance.
- 🔁 Recurring usage model: Unlike ancestry or inherited trait tests, our platform supports repeat testing per patient.
- 💡 Real-world pilot underway: We’re currently building partnerships with clinicians and sequencing providers to serve real patients.
- 🔐 Secure, GDPR-compliant: Data privacy and clinical integrity are foundational to our platform. We do not store patient data.
- 📈 Scalable model: Automated pipelines, modular architecture, and a focused target market position us for rapid expansion.
Our Vision
We envision a future where DNA analysis becomes as routine as bloodwork in medical care. WGSearcher will be part of the infrastructure that supports precision medicine based on liquid biopsies.
Join Us
We’re currently seeking additional investment to accelerate product development, expand clinical partnerships, and scale operations. If you’re passionate about the future of clinical genomics and want to be part of a transformative solution, we’d love to speak with you.